Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

Investigators Report Efficacy, Safety Analysis of Tarlatamab in SCLC Patients With or Without Baseline Brain Metastases

Data Look Promising for First-line Sotorasib, Platinum-based Chemotherapy Combination for KRAS-mutant NSCLC

Osimertinib Plus Chemotherapy May Improve CNS Activity in Advanced EGFR-positive NSCLC

Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor

Gender Disparity in Lung Cancer

BEAT-meso Trial Again Identifies Non-epithelioid Mesothelioma as Distinct Population

Concurrent IO with Chemoradiotherapy: Insights from PACIFIC-2

Big Tobacco Targets Medical Education

FLAURA-2 Results Lead to Approval of Osimertinib Plus Chemotherapy in European Union, Japan

IASLC to Celebrate 50 Years of International Collaboration, Education in Thoracic Oncology at WCLC 2024

Celebrate 5 Decades of the World Conference on Lung Cancer in San Diego’s Historic Gaslamp Quarter